METHOD FOR CULTURING STEM CELLS

• US 20080026460A1
• Filed: 06/20/2007
• Published: 01/31/2008
• Est. Priority Date: 06/20/2006
• Status: Active Application

• Current Assignee: Wisconsin Alumni Research Foundation (University of Wisconsin System)
• Original Assignee: Wisconsin Alumni Research Foundation (University of Wisconsin System)
• Inventors: Mohr, Jeffrey, De Pablo, Juan, Palecek, Sean
• Application Number:
  US11/765,831
• Publication Number:
  US 20080026460A1
• Time in Patent Office: Days
• US Class Current: 435/366
• CPC Class Codes: C12N 2501/115 Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 2502/13 connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
• CPC Class Codes: C12N 2533/30 Synthetic polymers
• CPC Class Codes: C12N 2533/90 Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
• CPC Class Codes: C12N 2535/10 Patterned coating
• CPC Class Codes: C12N 5/0603 Embryonic cells production of embryos, nuclear transfer A01K67/027; Embryoid bodies

Abstract

A three-dimensional microwell system that supports long term embryonic stem cell (ESCs) culture and formation of homogeneous embryoid bodies (EBs) is described. Microwell-cultured ESCs remain viable and undifferentiated for several weeks in culture and maintain undifferentiated replication when passaged to Matrigel®-coated, tissue culture-treated polystyrene dishes. Microwell-cultured ESCs maintain pluripotency, differentiating to each of the three embryonic germ layers. ESC aggregates released from microwells can be passaged for undifferentiated replication or differentiated to monodisperse EBs. The ability to constrain ESC growth in three dimensions advantageously provides for more efficient, reproducible culture of undifferentiated cells, high-throughput screening, and the ability to direct ESC differentiation by generating monodisperse EBs of a desired size and shape.

Claims

1. A method for culturing embryonic stem cells to obtain a population of embryoid bodies, the method comprising the steps of:

harvesting substantially undifferentiated embryonic stem cells from a dimension-constrained microwell; and

culturing the harvested embryonic stem cells under differentiating conditions to form the population of embryoid bodies.

2. A method as claimed in claim 1, wherein the population of embryoid bodies have a substantially uniform size and shape.

3. A method as claimed in claim 1, wherein the undifferentiated embryonic stem cells are selected from the group consisting of an embryonic stem cell colony and an aggregate of cells detached from an embryonic stem cell colony.

4. A method as claimed in claim 1, wherein the microwell is rectangular and has a lateral dimension between about 50 microns and about 600 microns.

5. A method as claimed in claim 1, wherein the microwell has a depth between about 10 microns and about 1000 microns.

6. A method as claimed in claim 1, wherein the harvesting step comprises shearing the embryonic stem cells from the microwell.

7. A method as claimed in claim 1, wherein the dimension-constrained microwell has cell-attracting and cell-repulsing portions.

8. An array comprising a substrate having a polymer coating thereupon, the coating defining a microwell on an upon surface thereof, the microwell having side walls and a bottom and having a cell-attractive portion and a cell-repulsing portion.

9. An array as recited in claim 8, wherein the microwells have rectangular lateral dimensions between about 50 microns and about 600 microns and a depth between about 10 microns and about 1000 microns.

10. An array as recited in claim 8, wherein the cell-attractive portion is coated with a cell-attractive material selected from the group consisting of Matrigel, gelatin, laminin, collagen, fibronectin, or a combination of the above.

11. An array as recited in claim 8, wherein the cell-repulsive potion is coated with a cell-repulsing alkanethiol material having a terminal moiety selected from the group consisting of poly-ethylene glycol containing three to six ethylene glycol groups and tri-ethylene glycol.

12. Undifferentiated human embryonic stem cell colonies having a substantially uniform size and shape.

13. The undifferentiated human embryonic stem cell colonies as recited in claim 12, wherein the colonies have rectangular lateral dimensions between about 50 microns and about 600 microns and depth between about 10 microns and about 1000 microns.

14. An embryonic stem cell-derived embryoid body having a substantially uniform size and shape.

15. A method of cryopreserving embryonic stem cells, comprising the step of:

freezing microwell-cultured, embryonic stem cells in microwells.

16. A method as recited in claim 15, wherein the microwells are rectangular and have a depth between about 10 microns and about 1000 microns with lateral dimensions between about 50 microns and about 600 microns.

17. A method for culturing embryonic stem cells, the method comprising the step of:

culturing substantially undifferentiated embryonic stem cells in a dimension-constrained microwell without subculture for at least about three weeks in a medium that does not promote differentiation, wherein greater than about 90% of the embryonic stem cells remain undifferentiated after about three weeks.